Balance Sheet Components (Tables)

3 Months Ended

Mar. 31, 2026

Balance Sheet Components [Abstract]

Schedule of Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets as of December 31, 2025 and March 31, 2026 consisted of the following (in thousands):

	As of		As of
	December 31,		March 31,
	2025		2026
Prepaid directors’ and officers’ liability insurance premiums	$	332	$	181
Prepaid drug manufacturing supply costs		6,189		7,689
Other		1,171		1,089
Total	$	7,692	$	8,959

Schedule of Property and Equipment

Property and equipment as of December 31, 2025 and March 31, 2026 consisted of the following (in thousands):

	As of			As of
	December 31,			March 31,
	2025			2026
Leasehold improvements	$	65		$	36
Lab equipment		26			26
Furniture and fixtures		47			44
Subtotal		138			106
Less accumulated depreciation		(72	)		(58	)
Net	$	66		$	48

Schedule of Accounts Payable

Accounts payable as of December 31, 2025 and March 31, 2026 consisted of the following (in thousands):

	As of		As of
	December 31,		March 31,
	2025		2026
Trade accounts payable	$	301	$	1,014
Credit card liability		82		126
Total	$	383	$	1,140

Schedule of Accrued Liabilities

Accrued liabilities as of December 31, 2025 and March 31, 2026 consisted of the following (in thousands):

	As of		As of
	December 31,		March 31,
	2025		2026
Accrued labor costs	$	329	$	768
Accrued drug development costs		753		631
Other		441		1,653
Total	$	1,523	$	3,052